FDA DEVICE FACTS
Armada™ 14 NC PTA Catheter
ABBOTT MEDICAL
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Armada™ 14 NC PTA Catheter is indicated to dilate stenosis in the peripheral vasculature, including femoral, infra-popliteal, popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The 2.0 mm to 6.0 mm balloon diameters are also indicated for post-dilatation of balloon-expandable stents, scaffolds (i.e., the Abbott Esprit™ BTK Everolimus Eluting Resorbable Scaffold System), and self-expanding stents in the peripheral vasculature.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。